ImmunoPrecise Antibodies Ltd.
HYFT
45.77 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.03
52 week high
2.21
high
2.04
52 week low
0.00
low
1.87
growth
-1.55 %
previous Close
2.01
P/E ratio
market cap
div yield
0
usd
Apr 2025
qoq
revenue
6.98 M
13.49 %
net incoming
-2.16 M
89.96 %
eps
0.00 %
92.87 %
eps surprise
0.00 %
net profit margin
-30.96 %
318.00 %
operating incoming
-1.46 M
55.72 %
net change in cash
-1.92 M
-120.77 %
cash on hand
10.67 M
-17.42 %
cost of revenue
2.52 M
-11.73 %
top top